SCHEMBL7087735

SCHEMBL7087735

CC1Oc2ccc(C(Cc3ccccc3Cl)NC(=O)OC(C)(C)C)cc2NC1=S

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.36
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 2/20 0.35
RCE1 Q9Y256 1/20 0.35
NPSR1 Q6W5P4 3/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
XBP1 P17861 2/20 0.35
HTT P42858 2/20 0.35
PLA2G1B P04054 1/20 0.35
ATG4B Q9Y4P1 1/20 0.35
SCN9A Q15858 1/20 0.34
SCN10A Q9Y5Y9 1/20 0.34
P4HB P07237 3/20 0.33
GAA P10253 2/20 0.33
POLB P06746 1/20 0.33
IDO1 P14902 1/20 0.33
LMNA P02545 2/20 0.33
MEN1 O00255 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7093383 0.91 MC4R (0.41) MC4RALDH1A1KDM4ERCE1NPSR1
SCHEMBL7708055 0.91 PARP1 (0.41) MC4RALDH1A1KDM4ERCE1NPSR1
SCHEMBL7095873 0.90 CTSS (0.42) ALDH1A1KDM4ERCE1NPSR1MAPT
SCHEMBL7704943 0.88 ALDH1A1 (0.43) ALDH1A1NPSR1MAPTHPGDXBP1
SCHEMBL7091085 0.87 NPSR1 (0.35) ALDH1A1KDM4ERCE1NPSR1MAPT
SCHEMBL7094067 0.87 HPGD (0.41) ALDH1A1KDM4ERCE1NPSR1MAPT
SCHEMBL7091267 0.86 HSD17B10 (0.33) ALDH1A1KDM4ERCE1NPSR1MAPT
SCHEMBL7092472 0.86 HSD17B10 (0.37) ALDH1A1NPSR1MAPTHPGDXBP1
SCHEMBL7708252 0.86 CTSL (0.45) ALDH1A1KDM4ERCE1NPSR1MAPT
SCHEMBL7708478 0.84 HSD17B10 (0.35) ALDH1A1NPSR1MAPTHPGDXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed